EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paraneoplastic neurological syndrome and its impact on the treatment outcomes of small‐cell lung cancer: A single‐center retrospective analysis

Yuki Sato iD, Satoru Fujiwara, Chigusa Shirakawa, Ryosuke Hirabayashi, Kazuma Nagata, Atsushi Nakagawa, Ryo Tachikawa, Keisuke Tomii

Thoracic Cancer · 2024-12 · 15 (34) · 2418-2427

DOI: 10.1111/1759-7714.15472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 19.10.2024. Verfasst von Yuki Sato und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Paraneoplastic Syndromes, Nervous System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Paraneoplastic neurological syndrome (PNS) is associated with small‐cell lung cancer (SCLC). However, the frequency and characteristics of PNS and the efficacy of anticancer treatment for these patients have not been investigated in the Japanese/Asian population previously. Therefore, we aimed to better understand PNS by evaluating real‐world data from patients with PNS complicated by SCLC.

Methods

Patients diagnosed with Stage II–IV SCLC at a single center between August 2007 and April 2021 were retrospectively analyzed. The primary outcome was the incidence of PNS. The secondary outcomes were the change in performance status (PS) after treatment commencement and outcomes following anticancer treatment, including objective response rate (ORR), progression‐free survival (PFS), and overall survival (OS).

Results

A total of 318 patients were evaluated; PNS was present in 2.8% ( n = 9) of the overall population. All patients with PNS exhibited poor Eastern Cooperative Oncology Group PS (≥2); moreover, 78% of patients had a PS score of 3–4. An improvement in PS was observed in 56% ( n = 5) of patients. Patients with PNS exhibited treatment efficacies similar to patients without PNS (ORR: 89% vs. 83%, p = 1.0; PFS: 7.6 vs. 5.7 months, p = 0.69; OS: not reached vs. 15.6 months, p = 0.23).

Conclusions

A total of 2.8% of patients had SCLC complicated by PNS, with poor PS observed. However, anticancer therapy led to an improvement in PS and comparable ORR, as well as PFS and OS similar to those observed in patients without PNS. Thus, anticancer therapy should be considered in patients with PNS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsParaneoplastic Syndromes, Nervous SystemHumansRetrospective StudiesMaleFemaleMiddle AgedAgedAdultTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

anticancer therapyparaneoplastic neurological syndromeperformance statussmall‐cell lung cancer

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Department of Neurology, Kobe City Medical Center General Hospital, Kobe, Japan.

ORCID-Profile: Yuki Sato

Zitieren

APA

Sato, Y., Fujiwara, S., Shirakawa, C., Hirabayashi, R., Nagata, K., Nakagawa, A., Tachikawa, R., & Tomii, K. (2024). Paraneoplastic neurological syndrome and its impact on the treatment outcomes of small‐cell lung cancer: A single‐center retrospective analysis. Thoracic Cancer, 15(34), 2418-2427. https://doi.org/10.1111/1759-7714.15472

Vancouver

Sato Y, Fujiwara S, Shirakawa C, Hirabayashi R, Nagata K, Nakagawa A, et al. Paraneoplastic neurological syndrome and its impact on the treatment outcomes of small‐cell lung cancer: A single‐center retrospective analysis. Thoracic Cancer. 2024;15(34):2418-2427. doi:10.1111/1759-7714.15472

BibTeX
@article{Sato2024,
  author = {Sato, Yuki and Fujiwara, Satoru and Shirakawa, Chigusa and Hirabayashi, Ryosuke and Nagata, Kazuma and Nakagawa, Atsushi and Tachikawa, Ryo and Tomii, Keisuke},
  title = {Paraneoplastic neurological syndrome and its impact on the treatment outcomes of small‐cell lung cancer: A single‐center retrospective analysis},
  journal = {Thoracic Cancer},
  year = {2024},
  volume = {15},
  number = {34},
  pages = {2418--2427},
  doi = {10.1111/1759-7714.15472}
}
Kostenlos starten →